The NIHR Invention for Innovation (i4i) Programme is a translational research funding scheme aimed at medical devices, in vitro diagnostic devices and digital health technologies addressing an existing or emerging health or social care need.
They fund innovations that have demonstrated proof-of-concept and have a clear pathway towards adoption and commercialisation.
The i4i programme has three funding streams: Product Development Awards (PDA), Challenge Awards and Connect. i4i FAST (Funding At the Speed of Translation) is a funding scheme aimed at innovators in need of a small amount of funding to answer a specific question or to fund a single piece of activity.
The i4i programme is participating in the NIHR-wide themed call on reducing compound pressures, focusing on generating high-quality research evidence into the evaluation of health and care interventions and services to reduce compound pressures on the NHS and social care. And is working in collaboration with the Office for Life Sciences (OLS) on the Addiction Mission: Innovation for Treatment and Recovery (AMI) Awards.
Cardiovascular disease remains one of the leading causes of illness and death worldwide, placing significant pressure on healthcare systems and highlighting the importance of early diagnosis and timely intervention. As digital health technologies continue to evolve, wearable devices and artificial…
Behind every successful healthcare system is a supply chain that ensures medicines, medical devices and essential equipment reach the right place at the right time. While often operating behind the scenes, healthcare logistics has become one of the most important…